期刊文献+

反式-(1R,2S)-2-(3,4-二氟苯基)-1-氨基环丙烷的合成工艺改进

Process Improvement on the Synthesis of Trans-(1R,2S)-2-( 3,4-difluorophenyl)-1-amino Trimethylene
下载PDF
导出
摘要 以3,4-二氟苯甲醛为起始原料,依次经缩合、酰卤化、酯化、不对称环丙烷化和霍夫曼降解反应制得中间体——反式-2-(3,4-二氟苯基)-1-氨基环丙烷[(±)-7];(±)-7与D-扁桃酸成盐后再水解合成了替格瑞洛关键中间体——反式-(1R,2S)-2-(3,4-二氟苯基)-1-氨基环丙烷,总收率24%,其结构经1H NMR和ESI-MS确证。 A intermediate, trans-2-( 3,4-difluorophenyl ) -1-amino trimethylene [ ( + ) -7 ], was prepared by condensation, acylation, esterification, asymmetric cyclopropanation and Hofmann degradation, using 3,4-difluorobenzaldehyde as the starting material. A key intermediate of Ticagrelor, trans- (1R,2S)-2-(3,4-difluorophenyl)-1-amino trimethylene, was synthesized in total yield of 24% by salifinstion of ( + )-7 with (R)-( - )-mandelic acid and then hydrolyzing. The structure was confirmed by 'H NMR and ESI-MS.
出处 《合成化学》 CAS CSCD 2015年第7期660-663,共4页 Chinese Journal of Synthetic Chemistry
基金 湖北省自然科学基金重点项目(2013CFA015) 湖北省高等学校优秀中青年科技创新团队项目(T200911)
关键词 替格瑞洛 药物中间体 药物合成 工艺改进 Ticagrelor drug intermediate synthesis process improvement
  • 相关文献

参考文献11

  • 1许学农.反式-(1R,2S)-2-(3,4-二氟苯基)环丙胺的制备方法[P].CN103242171A,2013.
  • 2Guile Simon, Astra Charnwood, Bakewell Road, et al. Novel compounds[ P]. WO 99/05 143,1999.
  • 3Gulle Simon, Astra Charnwood, Bakewell Road, et al. Novel triazolor ( 4, 5-D ) pyrimidine compounds [ P]. WO 00/34 283,2000.
  • 4Owen R T, Serradell A N. Therapy P2Yz reptor antag- onist[J]. Drugs of the Future,2007,32(10) :845 -853.
  • 5梁大伟(编译),董金华(审校).替格瑞洛(ticagrelor)[J].中国药物化学杂志,2011,21(6):509-510. 被引量:7
  • 6Rao Tadimeti, Zhang Chengzhi. Cyclopropyl modula- tors of P2Y,2 receptor[P]. WO 2 011 017 108,2011.
  • 7徐颂,于鹏,赵丽嘉,刘永贵,陈常青.盐酸替卡格雷[J].现代药物与临床,2010,25(1):64-66. 被引量:3
  • 8张建水,李晓军,刘烽,潘仙华.(1R,2S)-2-(3,4-二氟苯基)环丙胺的合成[J].精细化工,2013,30(1):64-68. 被引量:2
  • 9刘效祥,张强,高云,等.一种替卡格雷中间体的制备方法[P].CN102796007A,2012.
  • 10A Clarke, E Jones, U Larsson, et al. Process for preparation of cyclopropy carboxylic acid esters and derivatives[P]. CN 1 431 992A,2001.

二级参考文献22

  • 1Owen R T, Serradell N, Bolos J. AZD6140: antiplatelet therapy P2Y12(P2T) receptor antagonist [J]. Drug Fut, 2007, 32(10): 845-853.
  • 2Springthorpe B, Bailey A, Barton P, et al. From ATP to AZD6140: The diseovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis[J]. Bioorg Med Chem Lett, 2007, 17(21): 6013-6018.
  • 3Kowalczyk M, Banaeh M, Mikhailidis D P, et al. Tieagrelora new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? [J]. Med Sei Monit, 2009, 15(12): MS24-MS30.
  • 4Larsson U, Magnusson M, Musil T, et al. Novel triazole pyrimidine compounds: US, 2003148888A1 [P]. 2003-08-07.
  • 5Storey R F. New developments in antiplatelet therapy [J]. Eur Heart J, 2008, 10(Suppl D): 30-37.
  • 6Michelson A D. New P2Y12 antagonists [J]. Curr Opin Hematol, 2009, 16(5): 371-377.
  • 7Cattaneo M. New P2Y12 blockers [J]. J Thromb Haemost, 2009, 7(Suppl 1): 262-265.
  • 8Wallentin L, Becker R C, Budaj A, et al. Tieagrelor versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med, 2009, 361(11): 1045-1057.
  • 9AUFEDNBLATTEN R, BOLHIN M H, HELLS'FROM H, et al. A process for preparing[ 1S-[ 1α,2α,3β-( 1 S,2S) -5β]] -3- [ 7-[ 2-( 3,4-difluorophenyl ) -cyclopropylamino ] -5-( propy- lthil)-3H-1, 2, 3-triazolo [ 4, 5-d] pyrimidin-3-yl ]-5-( 2- hydroxyethoxy) cyclopentane-1,2-diol and to its intermedi- ates :WO,2010030224 [ P]. 2010 -03 - 18.
  • 10RAO T ,ZHANG C. Cyclopropyl modulators of P2Y12 recep- tor:WO,2011017108 [ P] .2011 -02 - 10.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部